AI assistant
Medpace Holdings, Inc. — Director's Dealing 2018
Sep 27, 2018
30442_dirs_2018-09-27_09c14890-4071-4b15-8abd-e7cf1a880339.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2018-09-25
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-25 | Common Stock | S | 38640 | $58.36 | Disposed | 8989174 | Direct |
| 2018-09-26 | Common Stock | S | 46886 | $58.38 | Disposed | 8942288 | Direct |
| 2018-09-27 | Common Stock | S | 46778 | $58.96 | Disposed | 8895510 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 20, 2018.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $58.82. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $59.29. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.00 to $59.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.